Inflammatory Marker but Not Adipokine Predicts Mortality among Long-Term Hemodialysis Patients
2007

Inflammatory Marker Predicts Mortality in Hemodialysis Patients

Sample size: 181 publication Evidence: moderate

Author Information

Author(s): Tsai Yu-Che, Lee Chien-Te, Huang Tiao-Lai, Cheng Ben-Chung, Kuo Chien-Chun, Su Yih, Ng Hwee-Yeong, Yang Chih-Chau, Chuang Fong-Rong, Liao Shang-Chih

Primary Institution: Chang-Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University, College of Medicine

Hypothesis

Can biomarkers of inflammation, adipokines, and clinical features predict the outcomes of hemodialysis patients?

Conclusion

Chronic inflammation and low albumin levels are strongly related to mortality in long-term hemodialysis patients.

Supporting Evidence

  • 41 out of 181 patients died during the 3-year follow-up period.
  • Elevated serum levels of hsCRP and albumin were highly associated with death.
  • Age, diabetes, albumin level, and hsCRP were independent factors predicting mortality.

Takeaway

This study found that patients on long-term dialysis who have high inflammation markers and low albumin levels are more likely to die.

Methodology

The study followed 181 hemodialysis patients for 36 months, analyzing demographic data, biomarkers, and clinical features to predict mortality.

Limitations

The study had a small sample size and a relatively short follow-up period.

Participant Demographics

The participants were 181 Taiwanese hemodialysis patients, with a mean age of 56.3 years, including 97 men.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1155/2007/19891

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication